Meet Dima Kuzmin, founding partner at 4BIO Capital, where he invests, supports and grows early stage companies developing treatments in areas of highly unmet medical needs, with an ultimate goal of ensuring access to these potentially curative therapies for all patients. Prior to becoming a VC, Dima was in academia, focusing successively on structural biology, neurochemistry, systems neuroscience, brain-computer interfaces, and gene therapy. It was when doing his PHD that his VC friends would ask him for help with scientific reviews that he got introduced to the opportunities helping investors with their scientific portfolio, and later founding 4BIO. Tune in to learn why he says that “genetic disease are the ultimate chronic disease” and how Covid was able to capture resources that were going elsewhere and successfully approve a vaccine that would typically take 10 years, in 11 months!